4 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Allergic Rhinitis: new trials by email Literature Review of Allergic Rhinitis trials Research Report on Allergic Rhinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis TQC3564 tablets, Placebo tablets, TQC3564 tablets, montelukast sodium tablets - Allergic Rhinitis | Phase 1 | Terminated | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 12 | 2022-09-14 | 2024-11-26 |
| Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections Dose Level 1, Dose Level 2, Placebo - Allergic Conjunctivitis, Allergic Rhinitis | Phase 1 | Terminated | Woodmont Pharmaceuticals, Inc. | 2 | 2017-03-30 | 2018-02-26 |
| Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients HollisterStier, Normal saline - Allergic Rhinitis | Phase 1 | Terminated | Gachon University Gil Medical Center | 24 | 2014-08-01 | 2016-08-11 |
| Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen AllerT SC, AllerT ID, Placebo SC - Allergic Rhinitis, Allergy | Phase 1 / Phase 2 | Terminated | Anergis | 29 | 2008-08-01 | 2012-11-20 |
Rhinitis, Allergic (4) · Conjunctivitis, Allergic (1) · Hypersensitivity (1)
Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Nose Diseases (4) · Otorhinolaryngologic Diseases (4) · Respiratory Hypersensitivity (4) · Respiratory Tract Diseases (4) · Rhinitis (4) · Hypersensitivity (3) · Conjunctival Diseases (1) · Conjunctivitis (1) · Eye Diseases (1)
Saline Solution (1) · montelukast (1)
Anergis (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Gachon University Gil Medical Center (1) · Woodmont Pharmaceuticals, Inc. (1)
China (1) · South Korea (1) · Switzerland (1) · United States (1)
Emily Schoemmell (1) · Francois Spertini, MD (1) · Sang Min Lee, M.D., Ph.D. (1)